DOP2002000457A - Tetrahidroquinolinas - Google Patents
TetrahidroquinolinasInfo
- Publication number
- DOP2002000457A DOP2002000457A DO2002000457A DO2002000457A DOP2002000457A DO P2002000457 A DOP2002000457 A DO P2002000457A DO 2002000457 A DO2002000457 A DO 2002000457A DO 2002000457 A DO2002000457 A DO 2002000457A DO P2002000457 A DOP2002000457 A DO P2002000457A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- tetrahydroquinolins
- medicines
- procedures
- preparation
- application refers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
La solicitud se refiere a derivados de tetrahidroquinolina, a procedimientos para su preparación y a su uso en medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10148436A DE10148436A1 (de) | 2001-10-01 | 2001-10-01 | Tetrahydrochinoline |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2002000457A true DOP2002000457A (es) | 2003-04-15 |
Family
ID=7701007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2002000457A DOP2002000457A (es) | 2001-10-01 | 2002-09-02 | Tetrahidroquinolinas |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050043341A1 (es) |
EP (1) | EP1434581A1 (es) |
JP (1) | JP2005508341A (es) |
AR (1) | AR036583A1 (es) |
CA (1) | CA2462030A1 (es) |
DE (1) | DE10148436A1 (es) |
DO (1) | DOP2002000457A (es) |
GT (1) | GT200200195A (es) |
HN (1) | HN2002000278A (es) |
PE (1) | PE20030604A1 (es) |
UY (1) | UY27458A1 (es) |
WO (1) | WO2003028727A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1670446A2 (en) | 2003-09-26 | 2006-06-21 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
DK1670768T3 (da) | 2003-10-08 | 2009-11-09 | Lilly Co Eli | Forbindelser og fremgangsmåder til at behandle dyslipidæmi |
DE602005008416D1 (de) | 2004-03-26 | 2008-09-04 | Lilly Co Eli | Verbindungen zur behandlung von dyslipidemie |
SI1828137T1 (sl) * | 2004-12-18 | 2012-08-31 | Bayer Pharma AG | 4-cikloalkil-substituirani derivati tetrahidrokinolina in njihova uporaba kot zdravila |
US20080194609A1 (en) * | 2004-12-18 | 2008-08-14 | Bayer Heathcare Ag | Chemical Compound and Its Use |
DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
US20080145498A1 (en) * | 2006-12-14 | 2008-06-19 | Kraft Foods Holdings, Inc. | Texture and shape control process for acidified food products |
JP5291126B2 (ja) * | 2008-03-05 | 2013-09-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 三環式ピリジン誘導体、そのような化合物を含有する医薬、それらの使用及びそれらの調製方法 |
JP5780528B2 (ja) | 2010-02-19 | 2015-09-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 三環式ピリジン誘導体、このような化合物を含有する医薬、それらの使用、およびそれらの調製方法 |
CN103221405B (zh) | 2010-07-09 | 2015-04-22 | 第一三共株式会社 | 取代的吡啶化合物 |
US9150583B2 (en) | 2011-08-17 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
JP6097225B2 (ja) * | 2012-01-06 | 2017-03-15 | 第一三共株式会社 | 置換ピリジン化合物の酸付加塩 |
EP3191441B1 (en) * | 2014-09-09 | 2020-02-19 | Boehringer Ingelheim International Trading (Shanghai) Co. Ltd. | Novel process for preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
DE19741051A1 (de) * | 1997-09-18 | 1999-03-25 | Bayer Ag | Hetero-Tetrahydrochinoline |
MA24643A1 (fr) * | 1997-09-18 | 1999-04-01 | Bayer Ag | Tetrahydro-naphtalenes substitues et composes analogues |
DE19741399A1 (de) * | 1997-09-19 | 1999-03-25 | Bayer Ag | Tetrahydrochinoline |
-
2001
- 2001-10-01 DE DE10148436A patent/DE10148436A1/de not_active Withdrawn
-
2002
- 2002-09-02 DO DO2002000457A patent/DOP2002000457A/es unknown
- 2002-09-18 US US10/491,465 patent/US20050043341A1/en not_active Abandoned
- 2002-09-18 CA CA002462030A patent/CA2462030A1/en not_active Abandoned
- 2002-09-18 JP JP2003532059A patent/JP2005508341A/ja active Pending
- 2002-09-18 WO PCT/EP2002/010444 patent/WO2003028727A1/de active Application Filing
- 2002-09-18 EP EP02772317A patent/EP1434581A1/de not_active Withdrawn
- 2002-09-25 AR ARP020103608A patent/AR036583A1/es unknown
- 2002-09-27 GT GT200200195A patent/GT200200195A/es unknown
- 2002-09-27 UY UY27458A patent/UY27458A1/es not_active Application Discontinuation
- 2002-09-30 PE PE2002000962A patent/PE20030604A1/es not_active Application Discontinuation
- 2002-10-01 HN HN2002000278A patent/HN2002000278A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2462030A1 (en) | 2003-04-10 |
DE10148436A1 (de) | 2003-04-17 |
GT200200195A (es) | 2003-08-22 |
WO2003028727A1 (de) | 2003-04-10 |
UY27458A1 (es) | 2003-04-30 |
EP1434581A1 (de) | 2004-07-07 |
AR036583A1 (es) | 2004-09-15 |
HN2002000278A (es) | 2002-12-20 |
PE20030604A1 (es) | 2003-09-07 |
JP2005508341A (ja) | 2005-03-31 |
WO2003028727A9 (de) | 2003-11-13 |
US20050043341A1 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04565B1 (et) | Adamantaani derivaadid, nende saamine ja kasutamine | |
EE200200197A (et) | 6-asendis asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena | |
EE200300409A (et) | Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina | |
EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
UY27098A1 (es) | Derivados de indol | |
SG146442A1 (en) | Sulphonamide derivatives, their preparation and use as medicaments | |
HN2001000281A (es) | Nuevas imidazotriazinonas sustituidas | |
EE200200175A (et) | Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine | |
DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
EE200300236A (et) | 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod | |
EE200300048A (et) | Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine | |
AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
EE200300327A (et) | Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon | |
NO20006138D0 (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
PT1500654E (pt) | Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos | |
DOP2002000457A (es) | Tetrahidroquinolinas | |
EE200300193A (et) | Asendatud bensimidasoolid, nende kasutamine ja ravim | |
BR0010709B1 (pt) | uso de lh para a produção de um medicamento para induzir a paucifoliculogênese ou unifoliculogênese em mulheres anovulatórias. | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
EE200300060A (et) | Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine | |
DE50213606D1 (de) | Zylinder im Falzapparat | |
PT1373249E (pt) | Derivados de imidazolidina, sua preparacao e sua utilizacao como agente anti-inflamatorio | |
AR025230A1 (es) | Procedimiento para preparar fosfonometilglicina. | |
EE200200266A (et) | 2-arüülkinoliini derivaadid, nende valmistamine ja kasutamine ravimites |